Rhythm Pharmaceuticals Competitors, Revenue, Alternatives and Pricing

Claim your profile


Boston, MA USA
Total Funding:$284.4M
Lead Investor(s):Pfizer Venture Investments

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Rhythm Pharmaceuticals's estimated annual revenue is currently $5.9M per year.(?)
  • Rhythm Pharmaceuticals received $41.0M in venture funding in February 2017.
  • Rhythm Pharmaceuticals's estimated revenue per employee is $46,378
  • Rhythm Pharmaceuticals's total funding is $284.4M.

Employee Data

  • Rhythm Pharmaceuticals has 127 Employees.(?)
  • Rhythm Pharmaceuticals grew their employee count by 22% last year.
  • Rhythm Pharmaceuticals currently has 1 job openings.

Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. Rhythm's lead product candidate is setmelanotide, a first-in-class melanocortin-4 receptor (MC4R) agonist. Rhythm supports The Genetic Obesity Project (GeneticObesity.com) and the GO-ID Genotyping Study (GeneticObesityID.com).

keywords:Biotechnology,Enterprise Software,Healthcare,Human Resources Hr,Pharmaceuticals